Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Potassium iodide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for potassium iodide and what is the scope of potassium iodide freedom to operate?

Potassium iodide
is the generic ingredient in five branded drugs marketed by Meda Pharms, Mission Pharmacal Co, Arco Pharms Llc, Recip, Roxane, and Anbex, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two hundred and twenty-seven drug master file entries for potassium iodide. Five suppliers are listed for this compound.

Summary for Generic Name: potassium iodide

Tradenames:5
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list227
Suppliers / Packagers: see list5
Bulk Api Vendors: see list85
Clinical Trials: see list254
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:potassium iodide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arco Pharms Llc
THYROSHIELD
potassium iodide
SOLUTION;ORAL077218-001Jan 12, 2005OTCNoYes► Subscribe► Subscribe
Mission Pharmacal Co
POTASSIUM IODIDE
potassium iodide
SOLUTION;ORAL206211-001Mar 24, 2016OTCNoNo► Subscribe► Subscribe
Roxane
POTASSIUM IODIDE
potassium iodide
SOLUTION;ORAL018551-001Feb 19, 1982DISCNNoNo► Subscribe► Subscribe
Meda Pharms
THYRO-BLOCK
potassium iodide
TABLET;ORAL018307-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Recip
THYROSAFE
potassium iodide
TABLET;ORAL076350-001Sep 10, 2002OTCNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot